SAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX011
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Copyright © 2026 Biotech Networks, LLC
